Cancer treatment’s biggest shift in decades creates big opportunity

After 50 Years of Chemo, One Biotech Looks to Lead the Next Multi-Billion-Dollar Cancer Breakthrough

For decades, chemotherapy has come at a heavy cost. Now, one biotech’s breakthrough delivery system could finally change that.

With early data showing precision without poison, this may be one of the most meaningful stories in biotech today.

See the full story and the company driving it forward

This email is a sponsored message sent on behalf of i2i Marketing Group, LLC, a third-party advertiser of MarketBeat. Why did I receive this message?.

We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.

If you need help with your newsletter, please don’t hesitate to contact MarketBeat’s U.S. based support team at contact@marketbeat.com.

If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.

Copyright 2006-2025 MarketBeat Media, LLC. All rights protected.
345 North Reid Place #620, Sioux Falls, S.D. 57103-7078. U.S.A..

Breaking Bread: An Honest Election Day Conversation — with Mike Nellis and Katie Phang

President’s Confession Here at Base Camp

RJ Hamster